118 related articles for article (PubMed ID: 36394644)
1. Importance of beta cell mass for glycaemic control in people with type 1 diabetes.
Jansen TJP; Brom M; Boss M; Buitinga M; Tack CJ; van Meijel LA; de Galan BE; Gotthardt M
Diabetologia; 2023 Feb; 66(2):367-375. PubMed ID: 36394644
[TBL] [Abstract][Full Text] [Related]
2. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging.
Cline GW; Naganawa M; Chen L; Chidsey K; Carvajal-Gonzalez S; Pawlak S; Rossulek M; Zhang Y; Bini J; McCarthy TJ; Carson RE; Calle RA
Diabetologia; 2018 Dec; 61(12):2598-2607. PubMed ID: 29721633
[TBL] [Abstract][Full Text] [Related]
3. Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes.
Gibb FW; McKnight JA; Clarke C; Strachan MWJ
Diabetologia; 2020 May; 63(5):906-914. PubMed ID: 32034440
[TBL] [Abstract][Full Text] [Related]
4. Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial.
Heiskanen MA; Motiani KK; Mari A; Saunavaara V; Eskelinen JJ; Virtanen KA; Koivumäki M; Löyttyniemi E; Nuutila P; Kalliokoski KK; Hannukainen JC
Diabetologia; 2018 Aug; 61(8):1817-1828. PubMed ID: 29717337
[TBL] [Abstract][Full Text] [Related]
5. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
[TBL] [Abstract][Full Text] [Related]
6. Association between time in range, a novel measurement of glycemic control and islet secretory function in chinese patients with type 2 diabetes mellitus-An observational study.
Xu SY; KeLi ; Zhang Z; Liu CY; Guo QY; Lu B; Gu P; Shao JQ
Diabetes Res Clin Pract; 2021 Mar; 173():108684. PubMed ID: 33539867
[TBL] [Abstract][Full Text] [Related]
7. The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.
Heimbürger SMN; Hoe B; Nielsen CN; Bergmann NC; Hartmann B; Holst JJ; Vilsbøll T; Dejgaard TF; Christensen MB; Knop FK
Diabetologia; 2021 Nov; 64(11):2425-2431. PubMed ID: 34405256
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation.
Brooks AM; Oram R; Home P; Steen N; Shaw JA
Diabetes Care; 2015 Jan; 38(1):105-12. PubMed ID: 25422169
[TBL] [Abstract][Full Text] [Related]
9. Postexercise Glycemic Control in Type 1 Diabetes Is Associated With Residual β-Cell Function.
Taylor GS; Smith K; Capper TE; Scragg JH; Bashir A; Flatt A; Stevenson EJ; McDonald TJ; Oram RA; Shaw JA; West DJ
Diabetes Care; 2020 Oct; 43(10):2362-2370. PubMed ID: 32747405
[TBL] [Abstract][Full Text] [Related]
10. Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.
Medina A; Parween S; Ullsten S; Vishnu N; Siu YT; Quach M; Bennet H; Balhuizen A; Åkesson L; Wierup N; Carlsson PO; Ahlgren U; Lernmark Å; Fex M
Diabetologia; 2018 Apr; 61(4):896-905. PubMed ID: 29209740
[TBL] [Abstract][Full Text] [Related]
11. Capturing the real-world benefit of residual β-cell function during clinically important time-periods in established Type 1 diabetes.
Taylor GS; Shaw AC; Smith K; Wason J; McDonald TJ; Oram RA; Stevenson E; Shaw JAM; West DJ
Diabet Med; 2022 May; 39(5):e14814. PubMed ID: 35181926
[TBL] [Abstract][Full Text] [Related]
12. First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [
Fujimoto H; Fujita N; Hamamatsu K; Murakami T; Nakamoto Y; Saga T; Ishimori T; Shimizu Y; Watanabe H; Sano K; Harada N; Nakamura H; Toyoda K; Kimura H; Nakagawa S; Hirai M; Murakami A; Ono M; Togashi K; Saji H; Inagaki N
Front Endocrinol (Lausanne); 2021; 12():717101. PubMed ID: 34489868
[TBL] [Abstract][Full Text] [Related]
13. Measuring the Pancreatic β Cell Mass in Vivo with Exendin SPECT during Hyperglycemia and Severe Insulitis.
Joosten L; Brom M; Peeters H; Bos D; Himpe E; Bouwens L; Boerman O; Gotthardt M
Mol Pharm; 2019 Sep; 16(9):4024-4030. PubMed ID: 31345042
[TBL] [Abstract][Full Text] [Related]
14. Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin.
Rosenfalck AM; Thorsby P; Kjems L; Birkeland K; Dejgaard A; Hanssen KF; Madsbad S
Acta Diabetol; 2000 Mar; 37(1):41-6. PubMed ID: 10928235
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
[TBL] [Abstract][Full Text] [Related]
16. Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs.
Luo M; Kong X; Wang H; Zhai X; Cai T; Ding B; Hu Y; Jing T; Su X; Li H; Ma J
J Diabetes Res; 2020; 2020():6666403. PubMed ID: 33299890
[TBL] [Abstract][Full Text] [Related]
17. Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: analysis of continuous glucose monitoring data from the INITIATION study.
Manski-Nankervis J; Yates CJ; Blackberry I; Furler J; Ginnivan L; Cohen N; Jenkins A; Vasanthakumar S; Gorelik A; Young D; Best J; O'Neal D
Diabet Med; 2016 Jun; 33(6):803-11. PubMed ID: 26435033
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice.
Wang Q; Brubaker PL
Diabetologia; 2002 Sep; 45(9):1263-73. PubMed ID: 12242459
[TBL] [Abstract][Full Text] [Related]
19. PET Imaging of Pancreatic Dopamine D
Bini J; Sanchez-Rangel E; Gallezot JD; Naganawa M; Nabulsi N; Lim K; Najafzadeh S; Shirali A; Ropchan J; Matuskey D; Huang Y; Herold KC; Harris PE; Sherwin RS; Carson RE; Cline GW
J Nucl Med; 2020 Apr; 61(4):570-576. PubMed ID: 31601695
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
